Concourse Financial Group Securities, Inc. Drug Manufacturers—Specialty & Generic

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ZTS Zoetis Inc.	$82.8B	$1.14 Million 0.07% of portfolio	5,812	Q3 2024 Added 0.09%
TAK Takeda Pharmaceutical CO LTD	$41.6B	$177,000 0.01% of portfolio	12,480	Q3 2024 Reduced 6.86%
HLN Haleon PLC	$44.1B	$84,000 0.01% of portfolio	7,999	Q3 2024 Reduced 19.17%
NBIX Neurocrine Biosciences Inc	$12B	$76,000 0.0% of portfolio	661	Q3 2024 Reduced 1.2%
LNTH Lantheus Holdings, Inc.	$6.22B	$48,000 0.0% of portfolio	440	Q3 2024 Reduced 2.65%
AMPH Amphastar Pharmaceuticals, Inc.	$2.23B	$46,000 0.0% of portfolio	959	Q3 2024 Added 2.02%
VTRS Viatris Inc	$16.2B	$29,000 0.0% of portfolio	2,565	Q3 2024 Added 30.87%
PRGO Perrigo CO PLC	$3.78B	$27,000 0.0% of portfolio	1,058	Q3 2024 Reduced 4.34%
BHC Bausch Health Companies Inc.	$2.88B	$4,000 0.0% of portfolio	500	Q3 2024 New
CTLT Catalent, Inc.	$11B	$3,000 0.0% of portfolio	50	Q3 2024 Reduced 93.07%
EOLS Evolus, Inc.	$707M	$2,000 0.0% of portfolio	154	Q1 2023 New
AKAN Akanda Corp.	$40.7M	$0 0.0% of portfolio	0	Q3 2024 New
ALKS Alkermes Plc.	$4.73B	$0 0.0% of portfolio	0	Q3 2024 Sold Out
TKNO Alpha Teknova, Inc.	$204M	$0 0.0% of portfolio	0	Q3 2024 New
ALVO Alvotech	$3.07B	$0 0.0% of portfolio	0	Q3 2024 New
AMRX Amneal Pharmaceuticals, Inc.	$1.27B	$0 0.0% of portfolio	0	Q3 2024 New
ANIP Ani Pharmaceuticals Inc	$992M	$0 0.0% of portfolio	0	Q3 2024 New
AQST Aquestive Therapeutics, Inc.	$245M	$0 0.0% of portfolio	0	Q3 2024 New
ASRT Assertio Holdings, Inc.	$46.7M	$0 0.0% of portfolio	0	Q3 2024 New
ATNX Athenex, Inc.	$1.57M	$0 0.0% of portfolio	0	Q3 2024 New
AYTU Aytu Biopharma, Inc	$93.6M	$0 0.0% of portfolio	0	Q3 2024 New
CRDL Cardiol Therapeutics Inc.	$98.5M	$0 0.0% of portfolio	0	Q3 2024 New
CPHI China Pharma Holdings, Inc.	$10.1M	$0 0.0% of portfolio	0	Q3 2024 New
COLL Collegium Pharmaceutical, Inc	$1.02B	$0 0.0% of portfolio	0	Q3 2024 New
CRON Cronos Group Inc.	$786M	$0 0.0% of portfolio	0	Q3 2024 New
CPIX Cumberland Pharmaceuticals Inc	$15.8M	$0 0.0% of portfolio	0	Q3 2024 New
CYTH Cyclo Therapeutics, Inc.	$5.82M	$0 0.0% of portfolio	0	Q3 2024 New
RDY Dr Reddys Laboratories LTD	$2.36B	$0 0.0% of portfolio	0	Q3 2024 New
DVAX Dynavax Technologies Corp	$1.57B	$0 0.0% of portfolio	0	Q3 2024 New
EGRX Eagle Pharmaceuticals, Inc.	$12.4M	$0 0.0% of portfolio	0	Q3 2024 New
ELAN Elanco Animal Health Inc	$6.33B	$0 0.0% of portfolio	0	Q3 2024 Sold Out
EMBC Embecta Corp.	$817M	$0 0.0% of portfolio	33	Q4 2023 Reduced 5.71%
EBS Emergent Bio Solutions Inc.	$473M	$0 0.0% of portfolio	0	Q3 2024 New
ESPR Esperion Therapeutics, Inc.	$168M	$0 0.0% of portfolio	0	Q3 2024 New
EVO Evotec Se	$1.59B	$0 0.0% of portfolio	0	Q3 2024 New
GRVI Grove, Inc.	$83.3M	$0 0.0% of portfolio	0	Q3 2024 New
HROW Harrow Health, Inc.	$1.19B	$0 0.0% of portfolio	0	Q3 2024 New
HCM Hutchmed (China) LTD	$3B	$0 0.0% of portfolio	0	Q3 2024 New
INCR Intercure Ltd.	$60.9M	$0 0.0% of portfolio	0	Q3 2024 New
ITCI Intra Cellular Therapies, Inc.	$8.09B	$0 0.0% of portfolio	0	Q3 2024 New
IRWD Ironwood Pharmaceuticals Inc	$527M	$0 0.0% of portfolio	0	Q3 2024 New
DERM Journey Medical Corp	$63.7M	$0 0.0% of portfolio	0	Q3 2024 New
JUPW Jupiter Wellness, Inc.	$64.5M	$0 0.0% of portfolio	0	Q3 2024 New
KMDA Kamada LTD	$262M	$0 0.0% of portfolio	0	Q3 2024 New
LNDC Landec Corp \Ca\	$0	$0 0.0% of portfolio	0	Q3 2024 New
LCI Lannett CO Inc	$1.29M	$0 0.0% of portfolio	0	Q3 2024 New
OPTN Opti Nose, Inc.	$40M	$0 0.0% of portfolio	0	Q3 2024 New
ORGO Organogenesis Holdings Inc.	$530M	$0 0.0% of portfolio	0	Q3 2024 New
PCRX Pacira Bio Sciences, Inc.	$804M	$0 0.0% of portfolio	0	Q3 2024 Sold Out
PETQ Pet Iq, Inc.	$908M	$0 0.0% of portfolio	0	Q3 2024 Sold Out

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.